VIVENTIA BIO

viventia-bio-logo

Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT). We believe our TPT based product candidates enjoy significant advantages in treating cancer versus earlier technologies.

#SimilarOrganizations #People #Website #More

VIVENTIA BIO

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1995-01-01

Address:
Winnipeg, Manitoba, Canada

Country:
Canada

Website Url:
http://www.viventia.com

Total Employee:
11+

Status:
Closed

Contact:
(204)478-1023

Email Addresses:
info@elevenbio.com

Technology used in webpage:
Domain Not Resolving SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DreamHost Hosting


Similar Organizations

endece-logo

Endece

Endece is a privately held bio-pharmaceutical company at the forefront of new discovery and development.

everon-biosciences-logo

Everon Biosciences

Everon Biosciences is a private biotechnology company specializing in the development of novel anti-aging therapeutics.

gentium-logo

Gentium

Gentium S.p.A. is public (GENT - NASDAQ) biopharmaceutical company specializing in the discovery, research, development and manufacture of

theracrine-logo

Theracrine

Theracrine Inc. is a private biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging

not_available_image

URL Pharma, Inc.

URL Pharma is a pharmaceuticals company specializing in drug research and development services.


Current Advisors List

greg-adams_image

Greg Adams Scientific Advisory Boards @ Viventia Bio
Advisor

Current Employees Featured

not_available_image

Leslie L. Dan
Leslie L. Dan Founder and Chairman @ Viventia Bio
Founder and Chairman

Founder


not_available_image

Leslie L. Dan

Official Site Inspections

http://www.viventia.com

  • Host name: 172.67.213.89
  • IP address: 172.67.213.89
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Viventia Bio"

Viventia Bio - Crunchbase Company Profile & Funding

Viventia Bio is the leader in developing next generation oncology therapeutics utilizing our proprietary Targeted Protein Therapeutic technology (TPT). We believe our TPT based …See details»

Viventia Bio Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Viventia Bio Inc of Winnipeg, MB. Get the latest business insights from Dun & Bradstreet.See details»

Viventia Bio Company Profile 2024: Valuation, Investors

Viventia Bio was founded in 1995. Where is Viventia Bio headquartered? Viventia Bio is headquartered in Winnipeg, Canada. What industry is Viventia Bio in? Viventia Bio’s primary …See details»

Viventia Biotech Inc., Etobicoke, Ontario - companylisting.ca

CA. Phone: (416) 291-1277. Fax: (416) 335-9306. Email: Click Here. Website: http://www.viventia.com. Viventia Biotech Inc. is a Canadian biopharmaceutical company …See details»

Organization | Viventia

Viventia Report issue. For profit. Founded: Winnipeg Canada (1995) Status: Acquired by Sesen Bio (2016 ...See details»

Viventia Bio Inc - Company Profile and News - Bloomberg …

Viventia Bio Inc. operates as a biologics oncology company. The Company designs, engineers and develops protein therapeutics.See details»

Viventia Bio Inc. - LinkedIn

Viventia Bio Inc. | 655 followers on LinkedIn. Sesen BioSee details»

Viventia - Products, Competitors, Financials, Employees, …

Viventia, fka Novopharm Biotech, is a biopharmaceutical company that designs, develops, engineers, and commercializes protein therapeutic technology and advanced monoclonal …See details»

BioPharmaLink profile of Viventia Biotech Inc., Canada, …

Viventia Biotech Inc. (formerly Novopharm Biotech Inc.) is a leading Canadian biopharmaceutical company engaged in the research, development and commercialization of both innovative and …See details»

Eleven Biotherapeutics Acquires Viventia Bio to Create …

Sep 21, 2016 Â· Viventia’s drug development is currently focused on locally administered targeted protein therapeutics (TPTs) for the treatment of cancer. Viventia’s TPTs are expressed as a …See details»

Eleven Biotherapeutics Acquires Viventia Bio

Sep 21, 2016 Â· Eleven Biotherapeutics has acquired Viventia Bio, the companies said today, in a deal that creates a combined developer of cancer therapies based on antibody fragments …See details»

Viventia Bio Inc. Careers and Employment | Indeed.com

Sep 20, 2017 Â· Find out what works well at Viventia Bio Inc. from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»

Viventia Biotech. Inc. - Winnipeg R3T 3Z1, 147 Hamelin St

Laboratories-Research & Development. Login Welcome to Kompass Global B2B portal where Buyers can find and contact the best product or service Suppliers!See details»

Eleven Biotherapeutics : Acquires Viventia Bio to Create …

Sep 21, 2016 Â· Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) and Viventia Bio Inc., today announced that the two companies and the shareholders of Viventia entered into a definitive …See details»

Viventia Biotech To Explore Strategic Alternatives

TORONTO, January 29 /PRNewswire/ -- Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody therapeutics focused on cancer, announced …See details»

Eleven Bio gets cancer focused with Viventia - BioPharma …

Sep 22, 2016 Â· Eleven Biotherapeutics has completed its acquisition of Viventia to create a company focused on targeted protein therapeutics. With the deal, Eleven gains a drug …See details»

Viventia Biotech to Explore Strategic Alternatives - Fierce …

TORONTO, Jan. 29 /PRNewswire/ - Viventia Biotech Inc., a privately held biopharmaceutical company advancing a portfolio of novel antibody therapeutics focused on cancer, announced …See details»

What is Viventia? Company Culture, Mission, Values

Viventia Biotech is a research and development biopharmaceutical company focused on finding monoclonal antibody therapies for the treatment of cancer. Its lead product candidate, ... Read …See details»

A Phase II Study of Oportuzumab Monatox: An …

From Viventia Biotechnologies Inc., Mississauga, Ontario (MK, JG, LB, CM) and Winnipeg, Manitoba (JE, JC, GCM), and Princess Margaret Hospital, Toronto (MASJ), Ontario Purpose: …See details»

IVC Vita Health | Winnipeg, Manitoba CANADA

G.W. Seier founded Vita Health Products in Winnipeg, Manitoba in 1936. Since then, the company has grown from a small mail-order operation selling herbs and patented medicines …See details»

linkstock.net © 2022. All rights reserved